Whilst low cost playing cards can help reduce the burden of significant drug fees from the short term, they don't handle the systemic troubles driving up prescription charges while in the U.S. Broader policy modifications could tackle the basis will cause of climbing drug selling prices, for example insufficient transparency in pricing and also the